| Literature DB >> 32194519 |
Yangmei Wang1, Yong Zhao1,2,3, Yingjie Pan1,2,3, Haiquan Liu1,2,3,4.
Abstract
Vibrio parahaemolyticus is a food-borne pathogen that causes pathogenic symptoms such as diarrhea and abdominal pain. Currently no studies have shown that either pathogenic and non-pathogenic V. parahaemolyticus possess growth heterogeneity in a human environment, such as in gastric and intestinal fluids. The tlh gene is present in both pathogenic and non-pathogenic V. parahaemolyticus strains, while the tdh and trh genes are only present in pathogenic strains. This study firstly applied simulated human gastric fluids to explore growth variability of 50 strains of V. parahaemolyticus at 37°C. The bacterial growth curves were fitted by primary modified Gompertz model, and the maximum growth rate (μ max ), lag time (LT), and their CV values were calculated to compare the stress response of pathogenic and non-pathogenic V. parahaemolyticus to simulated human gastric fluids. Results showed that the simulated human gastric fluids treatment significantly increased the μmax of pathogenic strains and shortened the lag time, while decreased the μmax of non-pathogenic strains and prolonged the lag time. Meanwhile, the CV values of genotypes (tlh +/tdh +/trh -) evidently increased, showing that the pathogenic genotype (tlh +/tdh +/trh -) strains had strong activity to simulated gastric fluids. All of the results indicated that the V. parahaemolyticus strains exhibited a great stress-resistant variability and growth heterogeneity to the simulated gastric fluids, which provides a novel insight to unlock the efficient control of pathogenic V. parahaemolyticus.Entities:
Keywords: Vibrio parahaemolyticus; gene heterogeneity; growth heterogeneity; maximum growth rate; simulate gastric fluids
Year: 2020 PMID: 32194519 PMCID: PMC7062715 DOI: 10.3389/fmicb.2020.00212
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
The sources and genotypes of 50 strains of V. parahaemolyticus.
| VPE01 | + | – | + | Freshwater | VPE48 | + | – | – | Freshwater |
| VPE02 | + | – | – | Seawater | VPE49 | + | – | – | Seawater |
| VPE03 | + | – | + | Freshwater | VPC16 | + | + | – | Pathogenic |
| VPE04 | + | – | – | Freshwater | VPC18 | + | + | – | Pathogenic |
| VPE05 | + | – | – | Seawater | VPC25 | + | + | – | Pathogenic |
| VPE07 | + | + | – | Seawater | VPC26 | + | + | – | Pathogenic |
| VPE08 | + | – | + | Freshwater | VPC29 | + | + | – | Pathogenic |
| VPE09 | + | + | – | Seawater | VPC32 | + | + | – | Pathogenic |
| VPE10 | + | + | – | Seawater | VPC36 | + | + | – | Pathogenic |
| VPE11 | + | – | – | Seawater | VPC40 | + | + | – | Pathogenic |
| VPE17 | + | + | – | Seawater | VPC41 | + | + | – | Pathogenic |
| VPE27 | + | – | – | Freshwater | VPC44 | + | + | – | Pathogenic |
| VPE28 | + | + | – | Freshwater | VPC45 | + | + | – | Pathogenic |
| VPE29 | + | – | + | Freshwater | VPC46 | + | + | – | Pathogenic |
| VPE32 | + | – | – | Seawater | VPC47 | + | + | – | Pathogenic |
| VPE36 | + | – | + | Freshwater | VPC49 | + | + | – | Pathogenic |
| VPE37 | + | + | – | Seawater | VPC50 | + | + | – | Pathogenic |
| VPE38 | + | – | – | Freshwater | VPC51 | + | + | – | Pathogenic |
| VPE40 | + | – | + | Freshwater | VPC54 | + | + | + | Pathogenic |
| VPE42 | + | + | + | Human | VPC55 | + | + | – | Pathogenic |
| VPE43 | + | + | – | Human | VPC89 | + | + | – | Pathogenic |
| VPE44 | + | – | – | Freshwater | VPC90 | + | + | – | Pathogenic |
| VPE45 | + | – | – | Seawater | VPC94 | + | – | + | Pathogenic |
| VPE46 | + | – | – | Freshwater | VPC97 | + | + | – | Pathogenic |
| VPE47 | + | – | – | Freshwater | VPC100 | + | + | – | Pathogenic |
FIGURE 1Maximum specific growth rates (μmax) of V. parahaemolyticus strains from different sources after SGF. (A) Maximum specific growth rate of environmental strains. (B) Maximum specific growth rate of pathogenic strains. (C) The change of maximum specific growth rate of environmental strains in SGF treatment. (D) The change of maximum specific growth rate of pathogenic strains in SGF treatment.
FIGURE 2The lag time (λ) of V. parahaemolyticus strains from different sources after SGF. (A) Lag time (λ) of environmental strains. (B) Lag time (λ) of pathogenic strains.
FIGURE 3Mean value curve of maximum specific growth rates (μmax) and coefficient of variation curve of μmax among strains (CV-Strain) after SGF treatment. (A) Mean value curve of maximum specific growth rates (μmax) and coefficient of variation curve of μmax among strains (CV-Strain) of environmental strain. (B) Mean value curve of maximum specific growth rates (μmax) and coefficient of variation curve of μmax among strains (CV-Strain) of pathogenic strain. (C) Mean value curve of lag time (λ) and coefficient of variation curve of lag time (λ) among strains (CV-Strain) of environmental strains. (D) Mean value curve of lag time (λ) and coefficient of variation curve of lag time (λ) among strains (CV-Strain) of pathogenic strains.
FIGURE 4The box plot between environment and pathogens for V. parahaemolyticus strains under gastric fluids treatment in the following growth conditions. (A) The environmental strains with P = 0.001 (control group and SGF treatment). (B) The pathogenic strains with P = 0.000 (control group and SGF treatment). (C) The environmental strains and pathogenic strains with P = 0.001 before SGF treatment. (D) The environmental strains and pathogenic strains with P = 0.000 after SGF treatment. ∗∗Statistical significance (p < 0.05).
FIGURE 5The influence of the genotype on the growth variability of V. parahaemolyticus strains from different sources. (A) Control group (not treated with SGF). (B) After SGF treatment.